- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05638685
The Bodily Complaints Barometer: The Impact of the Corona Measures and of Contracting a COVID-19 Infection on the Body. (COVID-MSK)
The Bodily Complaints Barometer: A Survey to Investigate the Impact of the Corona Measures and of Contracting a COVID-19 Infection on the Body.
Since December 2019, a new corona virus (SARS-CoV-2) causing COVID-19 disease, has expeditiously spread over the entire globe. Almost a half billion people caught the disease, and in those who survived, it soon became clear that residual complaints are not rare phenomena. Early focus lay on diminished lung capacity and cardiovascular-related problems. As time passed however, it became more apparent that those are not the only residual symptoms survivors may experience.
Furthermore, nearly every country in the world took some sort of lockdown measures in order to try contain the spreading of the virus. These measures had great impact on all inhabitants, infected with the virus or not.
This questionnaire-based study therefore aims to investigate (a) the effects of a COVID-19 infection on fatigue and/or musculoskeletal complaints, new or already existing, but also (b) the effects of lockdown measures on fatigue and/or musculoskeletal complaints, new or already existing, in people living, working or studying in Belgium during the pandemic.
Study Overview
Detailed Description
Since the start of the COVID-19 pandemic, almost half a billion people worldwide were infected with the new coronavirus, SARS-CoV-2, causing COVID-19 disease. In Belgium, 3.6 million people, a third of the population, contracted the disease. More than 30.000 patients did not survive this condition.
Many of those who did survive, however, complained of residual symptoms, even long after their infection. Initially the most reported and investigated complaints were lung and respiratory issues, but as time progressed, it became clear these were not the only residual problems after infection. A great deal of ex-patients reported lasting fatigue and musculoskeletal complaints, both myalgia and arthralgia, after they were deemed 'cured' and therefore discharged from the hospital. Since these complaints only became apparent when patients tried to resume their daily life outside the hospital, condsiderably less attention was given to these symptoms by clinicians and researchers. Therefore, this research aims to investigate the effects of a COVID-19 infection on fatigue and/or musculoskeletal complaints, both new or already existing.
In Belgium, as in many other countries all over the world, lockdown measures were installed to contain the spread of the virus. For certain periods, this meant an obligation to work from home and moreover, to only leave home for vital reasons. Before the pandemic, "telework" was rather exceptional; in a survey from September 2019, only 22% of respondents worked from home, and for just 1 day a week. So for many employees, this meant a hard transition from a fully ergonomic work space to an unadapted home environment. For those who used to walk or bike to work, physical activity levels dropped. Even more so since all sports and recreational facilities were ordered to close. Regardless of having to live through a COVID-19 infection, all these measures were of great impact on the population, and on their levels of physical activity. A second aim of this resaerch is thus to investigate the effect of lockdown measures on fatigue and/or musculoskeletal complaints, both new or already existing, in people living, working or studying in Belgium during these measures.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Oost-Vlaanderen
-
Ghent, Oost-Vlaanderen, Belgium, 9000
- Ghent University, vakgroep revalidatiewetenschappen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being at least 18 years old
- Living and/or working in Belgium
- Dutch speaking
Exclusion Criteria:
- Being younger than 18 years of age
- Not working or living in Belgium during the pandemic and lockdown measures
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Dutch-speaking people living or working in Belgium
Every participant was asked to complete a questionnaire about the impact of a COVID-19 infection and/or the impact of lockdown measures as a result of the COVID-19 pandemic on fatigue and musculoskeletal complaints.
|
The questionnaire comprises demographics, job or school related questions, screen work questions, the International Physical Activity Questionnaire (IPAQ) and questions about the participant's health.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Musculoskeletal complaints following a COVID-19 infection, through the International Physical Activities Questionnaire (IPAQ).
Time Frame: 3 months
|
3 months
|
|
|
Fatigue following a COVID-19 infection, through the Checklist Individual Strength (CIS).
Time Frame: 3 months
|
3 months
|
|
|
Musculoskeletal complaints caused by lockdown measures, through the IPAQ and the Short Inventory to Monitor Psychosocial Hazards.
Time Frame: 3 months
|
No prior COVID-19 infection
|
3 months
|
|
Fatigue caused by lockdown measures, through the CIS and the Short Inventory to Monitor Psychosocial Hazards.
Time Frame: 3 months
|
No prior COVID-19 infection
|
3 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Wrzesinski,D.& Kluppels, L. (2020) Telewerken gedurende COVID-19.Hoe beleven telewerkers het al of niet gedwongen thuiswerken? Brussel, België: Vias institute -INNO_DSU_MOBI
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B6702021000576
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
Clinical Trials on Questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University Medical Center GoettingenCompletedOrofacial Pain | Sleep ProblemsGermany
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Children's Hospitals and Clinics of MinnesotaCompletedFirearm Injury | Firearm Safety | Firearm OwnershipUnited States
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
University Hospital, Clermont-FerrandCompletedQuality of Life | Dentin HypersensitivityFrance